Literature DB >> 2731594

Chronic myelomonocytic leukemia--clinicobiological characteristics: a multivariate analysis in a series of 70 cases.

M C del Cañizo1, G Sanz, J F San Miguel, T Vallespi, D Irriguible, M Torrabadella, M A Sanz.   

Abstract

In a series of 70 patients diagnosed according to the FAB criteria, 42 clinical and biological disease characteristics were analyzed in order to identify significant prognostic factors by means of univariate and multivariate analysis. The univariate analysis identified ten parameters associated with poor prognosis: Symptoms of anemia, WBC over 10 x 10(9)/l, presence of blast cells, myeloid precursors or erythroblasts in peripheral blood (PB), high bone marrow (BM) cellularity, severe dysthrombopoiesis, percent of blast cells in BM and high serum levels of bilirubin and LDH. The Cox proportional hazards regression method revealed that the combination of high leukocyte counts and BM percentage of blast cells had the strongest predictive relation to survival length (p = 0.002 and p = 0.060 respectively). A new multivariate analysis treating the presence of myeloid and erythroid precursors in PB as a single variable selected only this as the most significant prognostic factor (p = 0.001). Both regression models allowed us to discriminate two significantly different risk groups of patients.

Entities:  

Mesh:

Year:  1989        PMID: 2731594     DOI: 10.1111/j.1600-0609.1989.tb01472.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  4 in total

1.  [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].

Authors:  U Germing; C Strupp; G Meckenstock; A Giagounidis; H Minning; C Aul
Journal:  Med Klin (Munich)       Date:  1999-09-15

2.  Cytogenetic risk stratification in chronic myelomonocytic leukemia.

Authors:  Esperanza Such; José Cervera; Dolors Costa; Francesc Solé; Teresa Vallespí; Elisa Luño; Rosa Collado; María J Calasanz; Jesús M Hernández-Rivas; Juan C Cigudosa; Benet Nomdedeu; Mar Mallo; Felix Carbonell; Javier Bueno; María T Ardanaz; Fernando Ramos; Mar Tormo; Reyes Sancho-Tello; Consuelo del Cañizo; Valle Gómez; Victor Marco; Blanca Xicoy; Santiago Bonanad; Carmen Pedro; Teresa Bernal; Guillermo F Sanz
Journal:  Haematologica       Date:  2010-11-25       Impact factor: 9.941

Review 3.  Models of Prognostication in Chronic Myelomonocytic Leukemia.

Authors:  Francesco Onida
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952

4.  Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia.

Authors:  Piyanuch Kongtim; Uday Popat; Antonio Jimenez; Sameh Gaballa; Riad El Fakih; Gabriela Rondon; Julianne Chen; Carlos Bueso-Ramos; Gautam Borthakur; Naveen Pemmaraju; Guillermo Garcia-Manero; Hagop Kantarjian; Amin Alousi; Chitra Hosing; Paolo Anderlini; Issa F Khouri; Partow Kebriaei; Borje S Andersson; Betul Oran; Katayoun Rezvani; David Marin; Elizabeth J Shpall; Richard E Champlin; Stefan O Ciurea
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-04       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.